Arkolith/Insider Trading/VRCA/Form 4

Rieger Jayson

CEO and President, DirectorVerrica Pharmaceuticals Inc. (VRCA) · full profile →Form 4 · filed Nov 25, 2025
Net Buying
Open-Market Buys
$400K
Open-Market Sells
$0
Net Open-Market Flow
$400K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 25, 2025Buy(P)94K$4.24$400K183K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 25, 2025Buy(P)24K——24K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0002043558-25-000003) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML